Preclinical evaluation of [(58m)Co]Co-DOTA-PSMA-617 for Auger electron therapy of prostate cancer

Prostate-specific membrane antigen (PSMA), highly expressed in prostate cancer, is a promising target for radionuclide therapy. Auger electron-emitting radionuclides are well suited for targeted radionuclide therapy if they can be delivered close to the DNA of the targeted cells. This preclinical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Baun, Christina, Dam, Johan Hygum, Hildebrandt, Malene Grubbe, Ewald, Jesper Dupont, Kristensen, Bjarne Winther, Gammelsrød, Vigga Sand, Olsen, Birgitte Brinkmann, Thisgaard, Helge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620164/
https://www.ncbi.nlm.nih.gov/pubmed/37914790
http://dx.doi.org/10.1038/s41598-023-43429-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620164/
https://www.ncbi.nlm.nih.gov/pubmed/37914790
http://dx.doi.org/10.1038/s41598-023-43429-8

Ejemplares similares